NSE
Wednesday, October 23, 2024    
Adani Enterp.  2835.55  (11.75)  
 
Adani Ports  1340.45  (-22.40)  
 
Apollo Hospita...  6906.75  (14.80)  
 
Asian Paints  2989.70  (-17.15)  
 
Axis Bank  1160.40  (-15.35)  
 
B P C L  323.05  (0.15)  
 
Bajaj Auto  10586.75  (218.40)  
 
Bajaj Finance  6995.80  (317.90)  
 
Bajaj Finserv  1739.70  (17.10)  
 
Bharat Electro...  268.65  (-3.00)  
 
Bharti Airtel  1685.80  (-6.45)  
 
Britannia Inds...  5748.85  (21.85)  
 
Cipla  1485.60  (-24.75)  
 
Coal India  474.10  (5.75)  
 
Dr Reddy's Lab...  6607.90  (-54.50)  
 
Eicher Motors  4677.75  (-81.30)  
 
Grasim Inds  2633.20  (-22.15)  
 
HCL Technologi...  1845.75  (23.00)  
 
HDFC Bank  1735.80  (21.25)  
 
HDFC Life Insu...  723.75  (-4.45)  
 
Hero Motocorp  5145.70  (-30.10)  
 
Hind. Unilever  2659.30  (-22.40)  
 
Hindalco Inds.  717.10  (-3.15)  
 
ICICI Bank  1251.60  (-15.90)  
 
IndusInd Bank  1274.30  (-0.05)  
 
Infosys  1873.40  (21.80)  
 
ITC  480.35  (-1.45)  
 
JSW Steel  954.45  (-9.20)  
 
Kotak Mah. Ban...  1767.80  (4.65)  
 
Larsen & Toubr...  3455.40  (-56.50)  
 
M & M  2793.50  (-93.70)  
 
Maruti Suzuki  11956.20  (32.90)  
 
Nestle India  2327.15  (-23.10)  
 
NTPC  408.30  (-7.45)  
 
O N G C  270.85  (0.05)  
 
Power Grid Cor...  316.90  (-5.85)  
 
Reliance Indus...  2677.05  (-9.65)  
 
SBI Life Insur...  1716.00  (17.85)  
 
Shriram Financ...  3197.75  (-56.75)  
 
St Bk of India  786.00  (-4.40)  
 
Sun Pharma.Ind...  1839.35  (-48.20)  
 
Tata Consumer  1014.55  (16.30)  
 
Tata Motors  877.65  (-1.85)  
 
Tata Steel  148.78  (-1.61)  
 
TCS  4066.25  (50.75)  
 
Tech Mahindra  1735.95  (39.40)  
 
Titan Company  3288.60  (-41.20)  
 
Trent  7511.30  (13.95)  
 
UltraTech Cem.  10753.05  (-72.10)  
 
Wipro  547.20  (1.75)  
 
BSE
Wednesday, October 23, 2024    
Adani Ports  1340.45  (-22.85)  
 
Asian Paints  2990.65  (-12.65)  
 
Axis Bank  1160.50  (-15.30)  
 
Bajaj Finance  6997.35  (319.95)  
 
Bajaj Finserv  1739.95  (16.75)  
 
Bharti Airtel  1685.00  (-6.75)  
 
HCL Technologi...  1846.00  (23.55)  
 
HDFC Bank  1735.70  (21.60)  
 
Hind. Unilever  2658.00  (-24.05)  
 
ICICI Bank  1251.55  (-16.20)  
 
IndusInd Bank  1272.15  (-2.15)  
 
Infosys  1872.85  (21.90)  
 
ITC  480.55  (-1.15)  
 
JSW Steel  954.50  (-9.85)  
 
Kotak Mah. Ban...  1765.85  (2.35)  
 
Larsen & Toubr...  3455.35  (-54.65)  
 
M & M  2790.50  (-93.10)  
 
Maruti Suzuki  11963.15  (42.25)  
 
Nestle India  2327.10  (-23.95)  
 
NTPC  408.25  (-7.25)  
 
Power Grid Cor...  316.80  (-6.00)  
 
Reliance Indus...  2677.70  (-9.60)  
 
St Bk of India  785.95  (-4.50)  
 
Sun Pharma.Ind...  1838.10  (-48.55)  
 
Tata Motors  877.25  (-2.05)  
 
Tata Steel  148.80  (-1.65)  
 
TCS  4066.75  (50.95)  
 
Tech Mahindra  1734.90  (38.70)  
 
Titan Company  3289.85  (-41.60)  
 
UltraTech Cem.  10752.20  (-65.15)  
 

Director's Report


Change Company Name
Johnson Pharmacare Ltd
Trading
BSE Code 532154 ISIN Demat INE560F01022 Book Value 1.03 NSE Symbol N.A Div & Yield % 0 Market Cap ( Cr.) 54.45 P/E 0 EPS 0 Face Value 1

<dhhead>D I R E C T O R S’ R E P O R T Dear Shareholders, </dhhead>

Your Directors here by present the 30th Annual Report together with the Audited statements of Accounts for the financial year ended on 31st March 2024.

 

OPERATIONS REVIEW:

During the year under review company not able to generate revenue from the operation and expenses were more so posted Net loss of Rs. 19,62,247/-

 

BRIEF DESCRIPTION OF THE COMPANY’S WORKING DURING THE YEAR/STATE OF THE COMPANY’S AFFAIR:

The Company does not have any significant business activity and not carried out any business during the year under review.

 

DIVIDEND:

Considering the loss incurred in the current financial year and accumulated losses, your Directors have not recommended dividend the financial under review.

 

TRANSFER TO RESERVES:

The Company has not transferred any amount to Reserves for the period under review.

 

SHARE CAPITAL: Authorized Capital:-

The authorized share capital of the Company stood at Rs. 55,00,00,000 (Rupees Fifty Five Crore only) divided into 55,00,00,000 (Fifty Five Crore) Equity Shares of Rs. 1/- (Rupees One only) each.

 

Paid up share Capital:

The issued, subscribed and paid up capital of the Company is Rs. 55,00,00,000/- divided into 55,00,00,000 equity shares of Rs 1/- each.

 

SUBSIDIARIES, JOINT VENTURES OR ASSOCIATE COMPANIES:

The Company does not have any subsidiary, associate companies & joint ventures.

 

DEPOSIT:

Your Company has not accepted any deposits within the meaning of Section 73 of the Companies Act, 2013 and the Companies (Acceptance of Deposits) Rules, 2014.

 

PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS:

Details of Loans, Guarantee or Investments made by your Company under Section 186 of the Companies Act, 2013 during the financial year 2023-24 is enclosed as an Annexure to this Board’s Report. During the year under review, the company has not provided any security falling within in purview of Section 186.

 

RELATED PARTY TRANSACTIONS:

All related party transactions that were entered into during the financial year were on arm’s length basis and were in the ordinary course of the business. There are no materially significant related party transactions made by the company with Promoters, Key Managerial Personnel or other designated persons which may have potential conflict with interest of the company at large.

 

MATERIAL CHANGES AND COMMITMENTS IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY:

No material changes and commitments affecting the financial position of the company have occurred between the end of financial year to which the financial statements relate and the date of the Directors’ Report.

SIGNIFICANT ORDERS PASSED BY THE REGULATORS, COURTS OR TRIBUNALS IMPACTING GOING CONCERN AND

COMPANY’S OPERATIONS:

To the best of our knowledge, the company has not received any such orders passed by the regulators, courts or tribunals during the year, which may impact the going concern status or company’s operations in future.

 

DIRECTORS AND KEY MANAGERIAL PERSONNEL:

As per the provisions of Section 152(6) of the Companies Act, 2013, Mr. RAMANLAL TRIVEDI (DIN- 01658705) shall retire by rotation at the ensuing Annual General Meeting and being eligible, has offered himself for re-appointment as the Director of the Company.

 

DECLARATION BY INDEPENDENT DIRECTORS:

The Company has received necessary declaration from each Independent Director under Section 149 (7) of the Companies Act, 2013, that they meet the criteria of independence laid down in Section 149(6) of the Companies Act, 2013.

 

MEETINGS:

The details of the number of meetings of the Board held during the Financial Year 2023-24 forms part of the Corporate Governance Report.

 

COMMITTEES OF THE BOARD:

The Board of Directors has the following Committees:

1. Audit Committee

2. Nomination and Remuneration Committee

3. Stakeholders’ Relationship Committee

The details of the Committees along with their composition, number of meetings and attendance at the meetings are provided in the Corporate Governance Report.

 

BOARD EVALUATION:

Pursuant to the provisions of the Schedule IV, clause VIII of the Companies Act, 2013 the Board has carried out an evaluation of its own performance, the directors individually as well as the evaluation of the working of its Audit, Appointment & Remuneration Committees. The performance evaluations of Independent Directors were also carried out and the same was noted. Independent Directors in their meeting decided to bring more transparency in their performance and bring more responsibility while taking any policy decisions for the benefit of the shareholders in general.

 

REMUNERATION OF THE DIRECTORS/ KEY MANAGERIAL PERSONNEL (KMP)/ EMPLOYEES:

No Directors/ Key Managerial Personnel are drawing any remuneration. Hence, the information required pursuant to Section 197 read with Rule 5 (1) (i) of The Companies (Appointment and Remuneration) Rules, 2014 in respect of ratio of remuneration of each director to the median remuneration of the employees of the Company for the Financial year is not given.

 

EXTRACT OF ANNUAL RETURN:

Pursuant to Section 92(3) read with Section 134(3) (a) of the Companies Act 2013, the Annual Return as on 31st March 2023 is available on the website of the Company at www.johnsonpharmacareltd.shop.

 

REPORT ON CORPORATE GOVERNANCE & MANAGEMENT DISCUSSION & ANALYSIS:

Pursuant to Regulation 34(3) read with Schedule V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Company has taken adequate steps to ensure that all mandatory provisions of Corporate Governance as prescribed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are complied with, a separate section titled Report on Corporate Governance together with a Certificate from the Practicing Company Secretary forms part of this Report.

A detailed Management Discussion & Analysis forms part of this Report.

 

CORPORATE SOCIAL RESPONSIBILITY INITIATIVES:

The Company has not developed and implemented any Corporate Social Responsibility initiative under the provisions of Section 135 of the Companies Act, 2013, read with Rule 9 of Companies (Corporate Social Responsibility Policy) Rules, 2014, as the said provisions are not applicable.

 

AUDITORS AND AUDITORS’ REPORT:

M/s. RISHI SEKHRI AND ASSOCIATES, CHARTERED ACCOUNTANTS, Mumbai (Firm Reg. No. 128216W), Statutory Auditors of the Company hold office until the conclusion of the next Annual General Meeting of the company.

The observations made by the Auditors’ in their Auditors’ Report and the Notes on Accounts referred to in the Auditors’

Report are self-explanatory and do not call for any further comments.

 

COST AUDITOR AND COST AUDIT REPORT:

Cost Audit is not applicable to your Company.